Henry Ford Health System

Henry Ford Health System Scholarly Commons
Case Reports

Medical Education Research Forum 2019

5-2019

Navigating a Request for LVAD Termination in the
Context of Depression
Suchi Nagaraj
Henry Ford Health System

Kristin Chasteen
Henry Ford Health System

Kelly Bryce
Henry Ford Health System

Karen Smith
Henry Ford Health System

Follow this and additional works at: https://scholarlycommons.henryford.com/merf2019caserpt
Recommended Citation
Nagaraj, Suchi; Chasteen, Kristin; Bryce, Kelly; and Smith, Karen, "Navigating a Request for LVAD Termination in the Context of
Depression" (2019). Case Reports. 41.
https://scholarlycommons.henryford.com/merf2019caserpt/41

This Poster is brought to you for free and open access by the Medical Education Research Forum 2019 at Henry Ford Health System Scholarly
Commons. It has been accepted for inclusion in Case Reports by an authorized administrator of Henry Ford Health System Scholarly Commons. For
more information, please contact acabrer4@hfhs.org.

Navigating a Request for LVAD Termination in the Context of Depression
S. Nagaraj MD, K. Chasteen MD, K. Bryce PhD, K. Smith LCSW PhD
Palliative Care, Behavioral Health, Ethics
Henry Ford Health System, Detroit, Michigan

Topic Focus
Taking into account a patient’s mental health in decision
making related to end of life and how to utilize an
interdisciplinary approach to facilitate the conversation.

Objectives
• Describe an approach to assessing capacity for end-of-life
decision making in a patient with depression
• Recognize the Interdisciplinary Team’s (IDT) approach to
navigating a patient’s request to discontinue a Left Ventricular
Assist Device (LVAD)
• Define the ethical principles that are involved in the decision to
withdraw LVAD therapy

Background
• There is ethical consensus that patients with capacity have the
right to stop any life-extending medical treatment, including an
LVAD.
• When a patient with depression requests discontinuation of an
LVAD, capacity for decision-making can be called into
question, particularly when there has been inconsistency in
expressed wishes.

• An Interdisciplinary approach is needed to navigate these
decisions.

LVAD
• LVAD therapy had first been introduced with the intent to be a
bridge to transplantation however, it as of late has become a
destination therapy.
•

The INTERMACS (Interagency Registry for Mechanically
Assisted Circulatory Support) --a group that generates
outcome data useful to programs with LVAD therapy at their
institutions-- has emphasized the importance of QOL
measures in the evaluation of LVADs.

Benefits & Risks with LVAD Implantation

Case
A 62 year-old man had a stroke one month after LVAD
implantation, resulting in hemiparesis, dependence for his basic
needs, and need for transition to a nursing facility. During an
admission two years later, he expressed that his quality of life
was poor and he wanted to stop his LVAD. He was found to be
depressed and grieving an unexpected loss. He accepted
treatment for depression and agreed with continuing LVAD
therapy. Two months later, he reported that while life at the
nursing facility was “not Disney World,” his quality of life was
acceptable. Two weeks later, he returned to the hospital
requesting LVAD termination. He acknowledged depressed
mood, but felt it stemmed entirely from his dependence on
others and would never improve. His wife supported his
decision and felt it was consistent with his long-standing
values. Behavioral health, palliative care, ethics, and the heart
failure team were involved. Although there was some evidence
of fluctuation in his wishes over time, team consensus was that
he had decision-making capacity and his request to discontinue
the LVAD should be honored.

Interdisciplinary Teams Involved
• Those involved in providing information and evaluating patient’s for LVAD
therapy all play a key role in deciding whether the patient is an appropriate
candidate to receive this specific therapy. Alternatively, the same teams come
together when decisions regarding its termination arise. They include:
• Cardiology/Advanced Heart Failure Team
• Palliative Care
• Social Work

Benefits: A better quality of life (less fatigue, more strength, and
better breathing) and longer survival. Some VAD patients have
been on support for up to seven years.
Complications: Bleeding, stroke, infection, and death.
Sometimes patients experience complications related to LVAD
therapy:
•
•
•
•
•
•
•
•
•

Bleeding
Gut
Brain
Clot
Stroke
Infection
Right heart dysfunction
Hemolysis
Damage to blood cells due to the pump

Post Implantation
• Understanding issues regarding psychiatric illness, adherence and
behavioral correlates of success in heart failure may identify feasible
strategies for optimizing care of LVAD patients.
• Depression and distress complicate post-transplant care.

• Psychiatric morbidity is associated with poor outcomes, including graft
rejection, non-adherence, hospitalizations, infection, and death.
•

With a high risk of embolic neurological events, patients’ ability for selfcare may be compromised.

Conclusion

• Behavioral Health

Left Ventricular Assist Device

Although extension of life is often seen as a benefit, we
respected the autonomy of this patient to determine that his
quality of life was unacceptable and continuing life-extending
treatment was not a benefit in his view. Depression was present
but given the persistence of the patient’s request, clear rationale
for his decision, and support from his wife, we respected his
choice.
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